Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

Amidst significant shifts in the pharmaceutical industry, the number of clinical trials has surged over the first half of ...

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

LabConnect, a leading global provider of central laboratory services today announced plans to form a strategic collaboration ...

Elutia (ELUT) announced the publication of clinical and preclinical data supporting the clinical utility of a biologic ...

The platform’s architecture allows it to handle everything from small single-site pilot trials to complex multi-phase ...

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

Clinical trial participants now expect clinical tools to match the usability of the digital tools they use every day.

A majority of cancer drugs approved in the US during 2019-2022 had “clinical trial uncertainties,” research suggests.

In this week’s Applied Clinical Trials Brief, we recap three top stories: Novo Nordisk’s stepwise approach to AI adoption, ...

Pfizer (PFE) and Moderna (MRNA) reveal trial data showing their updated COVID mRNA vaccines are safe and effective after ...